Table 1 Baseline clinical characteristics of validation cohort
Characteristic | Levels | Overall |
|---|---|---|
n | 62 | |
Group, n (%) | Lipomatous neoplasms | 12 (19.4%) |
Myomatous neoplasms | 7 (11.3%) | |
Nerve sheath tumors | 6 (9.7%) | |
Osteosarcoma | 32 (51.6%) | |
Synovial-like neoplasms | 5 (8.1%) | |
Gender, n (%) | Female | 23 (37.1%) |
Male | 39 (62.9%) | |
M/NM, n (%) | M | 30 (48.4%) |
NM | 32 (51.6%) | |
Survival status, n (%) | Alive | 32 (51.6%) |
Dead | 30 (48.4%) | |
Age (Years), median (IQR) | 24.5 (16.25, 34) | |
Survival time (Days), median (IQR) | 1613.5 (443, 2351) |